Nombre del producto:5-bromo-1,3-thiazol-2-amine

IUPAC Name:5-bromo-1,3-thiazol-2-amine

CAS:3034-22-8
Fórmula molecular:C3H3BrN2S
Pureza:97%
Número de catálogo:CM104786
Peso molecular:179.04

Unidad de embalaje Stock disponible Precio($) Cantidad
CM104786-25g in stock ŔǕ
CM104786-100g in stock ƞƄƄ
CM104786-500g in stock ňƻǯ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :3034-22-8
Fórmula molecular:C3H3BrN2S
Punto de fusión:-
Código de sonrisas:NC1=NC=C(Br)S1
Densidad:
Número de catálogo:CM104786
Peso molecular:179.04
Punto de ebullición:
Nº Mdl:MFCD00016893
Almacenamiento:

Category Infos

Thiazoles
Thiazoles are very important functional groups in medicinal chemistry. They act as ligands on a variety of biological matrices. Thiazoles are used in a wide range of therapeutic applications, such as antibacterial, antiretroviral, antifungal, antiallergic, antihypertensive, pain treatment, and to control symptoms of schizophrenia.

Column Infos

Cadisegliatin
vTv Therapeutics announces FDA submission for first phase 3 study of Cadisegliatin in patients with type 1 diabetes. Cadisegliatin (TTP399) is developed as an adjunctive therapy to insulin for the treatment of type 1 diabetes, and the phase 3 trial evaluates its safety and efficacy.
Glucokinase (GK) is mainly concentrated in liver cells, and involved in the regulation of glucose metabolism. Cadisegliatin (TTP399) is a liver-selective glucosekinase activator with a mechanism of action different from that of antidiabetic drugs. It binds to the allosteric site of GK and restores innate glucose-regulating capacity of the liver, not disrupting the interaction between GK and GKRP. Cadisegliatin previously received a Breakthrough Therapy designation from the U.S. FDA.